Zoetis Inc. (ZTS): Price and Financial Metrics
GET POWR RATINGS... FREE!
ZTS POWR Grades
- ZTS scores best on the Quality dimension, with a Quality rank ahead of 94.57% of US stocks.
- The strongest trend for ZTS is in Growth, which has been heading down over the past 179 days.
- ZTS ranks lowest in Momentum; there it ranks in the 15th percentile.
ZTS Stock Summary
- ZTS has a higher market value than 97.24% of US stocks; more precisely, its current market capitalization is $74,781,348,228.
- ZTS's one year PEG ratio, measuring expected growth in earnings next year relative to current common stock price is 582.07 -- higher than 95.09% of US-listed equities with positive expected earnings growth.
- Price to trailing twelve month operating cash flow for ZTS is currently 39.11, higher than 89.01% of US stocks with positive operating cash flow.
- If you're looking for stocks that are quantitatively similar to ZOETIS INC, a group of peers worth examining would be BSX, ABB, BDX, SYK, and A.
- ZTS's SEC filings can be seen here. And to visit ZOETIS INC's official web site, go to www.zoetis.com.
ZTS Valuation Summary
- In comparison to the median Healthcare stock, ZTS's EV/EBIT ratio is 327.48% higher, now standing at 28.
- ZTS's EV/EBIT ratio has moved down 12.9 over the prior 123 months.
Below are key valuation metrics over time for ZTS.
Stock | Date | P/S | P/B | P/E | EV/EBIT |
---|---|---|---|---|---|
ZTS | 2023-03-17 | 9.4 | 17.3 | 36.1 | 28.0 |
ZTS | 2023-03-16 | 9.5 | 17.5 | 36.5 | 28.3 |
ZTS | 2023-03-15 | 9.4 | 17.2 | 35.9 | 27.9 |
ZTS | 2023-03-14 | 9.4 | 17.3 | 36.1 | 28.0 |
ZTS | 2023-03-13 | 9.4 | 17.2 | 35.8 | 27.9 |
ZTS | 2023-03-10 | 9.3 | 17.0 | 35.4 | 27.6 |
ZTS Growth Metrics
- The 3 year net income to common stockholders growth rate now stands at 49.35%.
- Its year over year cash and equivalents growth rate is now at -12.97%.
- Its year over year net income to common stockholders growth rate is now at 16.85%.

The table below shows ZTS's growth in key financial areas (numbers in millions of US dollars).
Date | Revenue | Operating Cash Flow | Net Income to Common Stock |
---|---|---|---|
2022-12-31 | 8,080 | 1,912 | 2,114 |
2022-09-30 | 8,007 | 1,850 | 2,067 |
2022-06-30 | 7,995 | 1,977 | 2,090 |
2022-03-31 | 7,891 | 2,122 | 2,073 |
2021-12-31 | 7,776 | 2,213 | 2,037 |
2021-09-30 | 7,616 | 2,252 | 1,982 |
ZTS's Quality Factors
The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.- ZTS has a Quality Grade of A, ranking ahead of 95.14% of graded US stocks.
- ZTS's asset turnover comes in at 0.552 -- ranking 69th of 682 Pharmaceutical Products stocks.
- UTHR, ENDP, and MYGN are the stocks whose asset turnover ratios are most correlated with ZTS.
The table below shows ZTS's key quality metrics over time.
Period | Asset Turnover | Gross Margin | ROIC |
---|---|---|---|
2021-09-30 | 0.552 | 0.697 | 0.236 |
2021-06-30 | 0.537 | 0.695 | 0.233 |
2021-03-31 | 0.518 | 0.694 | 0.219 |
2020-12-31 | 0.514 | 0.692 | 0.206 |
2020-09-30 | 0.525 | 0.696 | 0.212 |
2020-06-30 | 0.535 | 0.697 | 0.207 |
ZTS Price Target
For more insight on analysts targets of ZTS, see our ZTS price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.
Average Price Target | $185.00 | Average Broker Recommendation | 1.34 (Strong Buy) |
ZTS Stock Price Chart Interactive Chart >
ZTS Price/Volume Stats
Current price | $164.18 | 52-week high | $201.32 |
Prev. close | $161.24 | 52-week low | $124.15 |
Day low | $159.97 | Volume | 1,864,800 |
Day high | $164.94 | Avg. volume | 2,224,075 |
50-day MA | $165.78 | Dividend yield | 0.93% |
200-day MA | $160.02 | Market Cap | 76.08B |
Zoetis Inc. (ZTS) Company Bio
Zoetis Inc. is an American drug company, the world's largest producer of medicine and vaccinations for pets and livestock. The company was a subsidiary of Pfizer, the world's largest drug maker, but with Pfizer's spinoff of its 83% interest in the firm it is now a completely independent company. The company directly markets the products in approximately 45 countries, and sells the products in more than 100 countries. Operations outside the United States accounted for 50% of the total revenue. Contemporaneous with the spinoff in June 2013 S&P Dow Jones Indices announced that Zoetis would replace First Horizon National Corporation in the S&P 500 stock market index. (Source:Wikipedia)
Latest ZTS News From Around the Web
Below are the latest news stories about ZOETIS INC that investors may wish to consider to help them evaluate ZTS as an investment opportunity.
Zoetis (ZTS) Dips More Than Broader Markets: What You Should KnowZoetis (ZTS) closed at $164.47 in the latest trading session, marking a -1.11% move from the prior day. |
The Zacks Analyst Blog Highlights Nike, Salesforce, Zoetis, Archer-Daniels-Midland and Trane TechnologiesNike, Salesforce, Zoetis, Archer-Daniels-Midland and Trane Technologies are part of the Zacks top Analyst Blog. |
Top Research Reports for Nike, Salesforce & ZoetisToday's Research Daily features new research reports on 16 major stocks, including NIKE, Inc. (NKE), Salesforce, Inc. (CRM) and Zoetis Inc. (ZTS). |
Zoetis (ZTS) Down 6.5% Since Last Earnings Report: Can It Rebound?Zoetis (ZTS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues. |
Zoetis Named One of the World’s Most Ethical Companies by EthispherePARSIPPANY, N.J., March 13, 2023--Zoetis Inc. (NYSE:ZTS) has been recognized by Ethisphere, a global leader in defining and advancing the standards of ethical business practices, as one of the 2023 World’s Most Ethical Companies. In 2023, 135 honorees were recognized, spanning 19 countries and 46 industries. Zoetis is one of three pharmaceutical companies and the only standalone animal health company included on the list. |
ZTS Price Returns
1-mo | -1.29% |
3-mo | N/A |
6-mo | 10.39% |
1-year | -12.63% |
3-year | 41.97% |
5-year | 106.98% |
YTD | 12.29% |
2022 | -39.51% |
2021 | 48.26% |
2020 | 25.76% |
2019 | 55.71% |
2018 | 19.45% |
ZTS Dividends
Ex-Dividend Date | Type | Payout Amount | Change | ||||||
---|---|---|---|---|---|---|---|---|---|
Loading, please wait... |
Continue Researching ZTS
Here are a few links from around the web to help you further your research on Zoetis Inc's stock as an investment opportunity:Zoetis Inc (ZTS) Stock Price | Nasdaq
Zoetis Inc (ZTS) Stock Quote, History and News - Yahoo Finance
Zoetis Inc (ZTS) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...